FindTrial
Sign In

Application of double filtration plasma pheresis in severe acute pancreatitis

Application of DFPP technology in severe acute pancreatitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093966
Enrollment
Unknown
Registered
2024-12-15
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute pancreatitis

Interventions

experimetal group()DFPP group):DFPP
control group:ural care

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: It meets the diagnostic criteria of severe acute pancreatitis

Exclusion criteria

Exclusion criteria: Patients under 18 years old with contraindications to central venipentesis and a history of severe allergy to plasma, human blood albumin, heparin, etc

Design outcomes

Primary

MeasureTime frame
IL-6;IL-8;TNF-a;CRP;—

Countries

China

Contacts

Public ContactYu Chen

Lanzhou University Second Hospital

chenyu14@lzu.edu.cn+86 184 0944 5050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026